Smart insulin pump could transform hospital diabetes care

NCT ID NCT07645079

Not yet recruiting Disease control Sponsor: Steno Diabetes Center Copenhagen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial compares an automated insulin delivery system (AID) to standard insulin injections for managing blood sugar in hospitalized adults with type 2 diabetes who have an infection. The AID system uses a continuous glucose monitor and a smart pump to automatically adjust insulin. The study aims to see if the AID system keeps blood sugar in a healthy range better than usual care. Participants are randomly assigned to either the AID system or standard insulin therapy, and their blood sugar levels are tracked throughout their hospital stay.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: automated insulin delivery system (mylife YpsoPump with FreeStyle Libre 3 sensor)
What this could lead to: If successful, this could show that automated insulin delivery is safer and more effective than standard care for managing blood sugar in hospitalized patients with type 2 diabetes.
What could go wrong: This is a relatively small trial (92 participants) and results may not apply to all hospitals or patient groups. The device may not work as well in sicker patients or could have technical issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CGM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congenital primary megaureter Infections infectious disease type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CGM DIABETES MELLITUS, TYPE 2 INFECTION

Contacts and locations

Locations

Steno Diabetes Center Copenhagen

Copenhagen, 2730, Denmark
University Hospital of Graz

Graz, Styria, 8036, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.